{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T19:43:38Z","timestamp":1776627818396,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jpba.2021.114264","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T11:57:10Z","timestamp":1626177430000},"page":"114264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry"],"prefix":"10.1016","volume":"204","author":[{"given":"Ana Carolina","family":"Ferreira Ballest\u00ea Ajorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin\u00edcius","family":"Pessanha Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson","family":"Peclat Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipe","family":"Merc\u00eas Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Alvaro Diniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josiane","family":"Machado Vieira Mattoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Barbosa da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"da Silva Guedes Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1121-7312","authenticated-orcid":false,"given":"Marcelo Luiz","family":"Lima Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpba.2021.114264_bib0005","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jpba.2021.114264_bib0010","series-title":"Coordena\u00e7\u00e3o-Geral De Planejamento Estrat\u00e9gico \u2013 Cogeplan\/Fiocruz Rio De Janeiro \u2013 RJ","first-page":"138","article-title":"Relat\u00f3rio de gest\u00e3o do exerc\u00edcio de 2019","author":"Funda\u00e7\u00e3o Oswaldo Cruz \u2013 FIOCRUZ","year":"2019"},{"issue":"3","key":"10.1016\/j.jpba.2021.114264_bib0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biologicals.2005.09.005","article-title":"Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102\/84 with an additional passage in chicken embryos","volume":"34","author":"Marchevsky","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.jpba.2021.114264_bib0020","series-title":"Technical Report No. 29: Points to Consider for Cleaning Validation","author":"Parenteral Drug Association \u2013 PDA","year":"2012"},{"issue":"6","key":"10.1016\/j.jpba.2021.114264_bib0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5731\/pdajpst.2011.00820","article-title":"Risk mitigation strategies for viral contamination of biotechnology products: consideration of best practices","volume":"65","author":"Rosenberg","year":"2011","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"6","key":"10.1016\/j.jpba.2021.114264_bib0030","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.vaccine.2015.12.041","article-title":"Inactivation of rabies virus by hydrogen peroxide","volume":"34","author":"Abd-Elghaffar","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2021.114264_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biologicals.2020.02.002","article-title":"Virus disinfection for biotechnology applications: different effectiveness on surface versus in suspension","volume":"64","author":"Kindermann","year":"2020","journal-title":"Biologicals"},{"issue":"5","key":"10.1016\/j.jpba.2021.114264_bib0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1472-765X.2011.03033.x","article-title":"Hydrogen peroxide vapour (HPV) inactivation of adenovirus","volume":"52","author":"Berrie","year":"2011","journal-title":"Lett. Appl. Microbiol."},{"issue":"2","key":"10.1016\/j.jpba.2021.114264_bib0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhin.2011.10.012","article-title":"Virucidal efficacy of hydrogen peroxide vapour disinfection","volume":"80","author":"Tuladhar","year":"2012","journal-title":"J. Hosp. Infect."},{"issue":"4","key":"10.1016\/j.jpba.2021.114264_bib0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhin.2014.02.003","article-title":"Evaluating the virucidal efficacy of hydrogen peroxide vapour","volume":"86","author":"Goyal","year":"2014","journal-title":"J. Hosp. Infect."},{"issue":"4","key":"10.1016\/j.jpba.2021.114264_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/lam.13203","article-title":"Hydrogen peroxide vapour is an effective replacement for Formaldehyde in a BSL4 Foot and mouth disease vaccine manufacturing facility","volume":"69","author":"Vannier","year":"2019","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.jpba.2021.114264_bib0060","series-title":"Code of Federal Regulations CITE:21CFR184.1366, Sec. 184.1366 Hydrogen Peroxide","author":"United States of America Food and Drug Administration - U.S. FDA","year":"2020"},{"issue":"2","key":"10.1016\/j.jpba.2021.114264_bib0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4315\/0362-028X-72.2.412","article-title":"Hydrogen peroxide vapor: a novel method for the environmental control of lactococcal bacteriophages","volume":"72","author":"Otter","year":"2009","journal-title":"J. Food Prot."},{"issue":"1","key":"10.1016\/j.jpba.2021.114264_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2012.10.002","article-title":"The role of\u2019 no-touch\u2019 automated room disinfection systems in infection prevention and control","volume":"83","author":"Otter","year":"2013","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.jpba.2021.114264_bib0075","first-page":"31","article-title":"A summary on cutting edge advancements in sterilization and cleaning technologies in medical, food, and drug industries, and its applicability to spacecraft hardware","volume":"23","author":"Gradini","year":"2019","journal-title":"Life Sci. Space Res. (Amst)."},{"issue":"4","key":"10.1016\/j.jpba.2021.114264_bib0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhin.2007.05.005","article-title":"Resistance of surface-dried virus to common disinfection procedures","volume":"66","author":"Terpstra","year":"2007","journal-title":"J. Hosp. Infect."},{"issue":"1","key":"10.1016\/j.jpba.2021.114264_bib0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhin.2009.08.020","article-title":"Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses","volume":"74","author":"Pottage","year":"2010","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.jpba.2021.114264_bib0090","series-title":"6\u00aa Edi\u00e7\u00e3o - Produtos Biol\u00f3gicos","author":"Brasil","year":"2019"},{"issue":"4","key":"10.1016\/j.jpba.2021.114264_bib0095","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/AAC.50.4.1419-1424.2006","article-title":"Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities","volume":"50","author":"Rutala","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2021.114264_bib0100","series-title":"13408-6:2021 Aseptic Processing of Healthcare Products - Part 6: Isolator Systems","author":"International Standards Organization","year":"2021"},{"key":"10.1016\/j.jpba.2021.114264_bib0105","series-title":"NF T 72-281. Procedes De Disinfection Des Surfaces Par Voie Aerienneedetermination De l\u2019activite Bactericide, Fongicide, Levuricide, Mycobactericide, Tuberculocide, Sporicide Et Virucide Incluant Les Bacteriophages","author":"L\u2019Association Francaise de Normalisation","year":"2014"},{"issue":"3","key":"10.1016\/j.jpba.2021.114264_bib0110","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jhin.2018.05.006","article-title":"Standard test method for automated airborne disinfection systems","volume":"100","author":"Chewins","year":"2018","journal-title":"J. Hosp. Infect."},{"issue":"4","key":"10.1016\/j.jpba.2021.114264_bib0115","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jhin.2017.09.011","article-title":"Test parameters for efficacy evaluations of aerial hydrogen peroxide decontamination systems","volume":"98","author":"Ali","year":"2018","journal-title":"J. Hosp. Infect."},{"issue":"10","key":"10.1016\/j.jpba.2021.114264_bib0120","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/jac\/dkq308","article-title":"Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms","volume":"65","author":"Finnegan","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jpba.2021.114264_bib0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/ani10010126","article-title":"Embryonic thermal manipulation affects the antioxidant response to post-hatch thermal exposure in broiler chickens","volume":"10","author":"Saleh","year":"2020","journal-title":"Animals (Basel)."},{"key":"10.1016\/j.jpba.2021.114264_bib0130","series-title":"WHO Team: Health Product Policy and Standards, Technical Standards and Specifications. WHO Technical Report Series, No. 999, Annex 2, 2016","article-title":"WHO good manufacturing practices for biological products","author":"World Health Organization \u2013 WHO","year":"2016"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521003757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521003757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:15:25Z","timestamp":1760001325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521003757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":26,"alternative-id":["S0731708521003757"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114264","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114264"}}